Europe ECMO Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Modality (Venoarterial ECMO, Venovenous ECMO, and Arteriovenous ECMO), Application (Respiratory and Cardiology), and Age Group (Adults, Pediatrics, and Neonates) 

Code: BMIRE00027917 | Pages: 126 | Industry: Medical Device | Date: Jan 2023 | Type: Regional

The Europe ECMO market is expected to grow from US$ 141.83 million in 2022 to US$ 166.97 million by 2028. It is estimated to record a CAGR of 2.8% from 2022 to 2028.      

 

Rising Prevalence of Cardiovascular Diseases and Respiratory Failures Drives Europe ECMO Market

 

Extracorporeal membrane oxygenation (ECMO) is a heart–lungs bypass machine. ECMO equipment is used in the treatment of cardiovascular diseases and respiratory failures. Millions of deaths due to cardiovascular diseases (CVDs) are recorded every year across Europe. CVDs majorly cause mortality and morbidity in Europe, accounting for 45% of deaths in the region and 37% in the European Union (EU). Chronic obstructive pulmonary disease (COPD) causes obstruction in the airflow from the lungs, which can lead to respiratory failure. It is one of the life-threatening illnesses that cause millions of deaths across the region. According to World Health Organization (WHO), in 2022, COPD was the third leading cause of death. About 90% of COPD deaths occur in low- and middle-income countries. Therefore, the growing prevalence of cardiovascular diseases and respiratory failures drives the growth of the Europe ECMO market.

 

Europe ECMO Market Overview 

 

The Europe ECMO market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany dominated the market in 2022. Heart attack is the most serious consequence of coronary heart disease (CHD). More than 3.6 million people suffer from CHD, and more than 1.3 million have survived a stroke. The prevalence of CHD is rising in Germany. According to the latest WHO data published in 2020, Germany recorded 147,055 CHD deaths, or 20.98% of total deaths.  Moreover, chronic obstructive pulmonary disease (COPD) has a high prevalence rate in Germany, and a further increase is expected in the coming years. In 2020, the number of isolated heart transplantations increased to 340, a rise of 2.1% compared with the previous year. However, the isolated lung transplantations amounted to 291, a decrease of 6.4%. The use of ECMO is still increasing, and a substantial proportion of hospitals perform very few ECMO runs. Small hospitals had significantly higher mortality, but dependence on hospital size and ECMO mortality was irregular. VV-ECMO was used for patients affected by COVID-19-related respiratory failure. The applications of extracorporeal circulation for mechanical support in cardiac and circulatory failure, which are referred to as extracorporeal life support (ECLS) or veno-arterial extracorporeal membrane oxygenation (VA-ECMO), have dramatically increased over the past decade in Germany from <300 cases in 2010 to 2,852 in 2020. During COVID-19 outbreak, in-hospital mortality in Germany was 68%. This is markedly higher than that reported by other countries or international registries. Thus, the above factors are expected to bolster the ECMO market during the forecast period.

 

Europe ECMO Market Revenue and Forecast to 2028 (US$ Million) 

   

Europe ECMO Market Revenue and Forecast to 2028 (US$ Million) 

Get more information on this report :

Europe ECMO Market Segmentation

 

The Europe ECMO market is segmented based on modality, application, age group, and country.    

 

Based on modality, the Europe ECMO market is segmented into venoarterial ECMO, venovenous ECMO, and arteriovenous ECMO. The venoarterial ECMO segment held the largest market share in 2022.

Based on application, the Europe ECMO market is bifurcated into respiratory and cardiology. The respiratory segment held a larger market share in 2022.

 

Based on age group, the Europe ECMO market is segmented into adults, pediatrics, and neonates. The adults segment held the largest market share in 2022.

 

Based on country, the Europe ECMO market has been categorized into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Our regional analysis states that Germany dominated the market in 2022.    

 

ABIOMED Inc, Braile Biomedica, Eurosets S.R.L., Fresenius Medical Care AG & Co KGaA, Getinge AB, LivaNova Plc, Medtronic Plc, MicroPort Scientific Corporation, Nipro Medical Corporation, and Terumo Group are the leading companies operating in the Europe ECMO market. 

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Europe ECMO Market – By Modality

1.3.2        Europe ECMO Market – By Application

1.3.3        Europe ECMO Market – By Age Group

1.3.4        Europe ECMO Market – By Country

2.           Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Europe ECMO Market – Market Landscape

4.1         Overview

4.2         Europe PEST Analysis

4.3         Experts Opinion

5.           Europe ECMO Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Rising Prevalence of Cardiovascular Diseases and Respiratory Failures

5.1.2        Growing Adoption of ECMO in Lung Transplantation Procedures

5.2         Market Restraints

5.2.1        Complications Associated with ECMO

5.3         Market Opportunities

5.3.1        Increasing Survival Rates with ECMO

5.4         Future Trends

5.4.1        Surging Product Developments and Approvals

5.5         Impact Analysis

6.           ECMO Market – Europe Analysis

6.1         Europe ECMO Market Revenue Forecast & Analysis

7.           Europe ECMO Market Analysis – By Modality

7.1         Overview

7.2         Europe ECMO Market Share by Modality 2021 & 2028 (%)

7.3         Venoarterial ECMO

7.3.1        Overview

7.3.2        Venoarterial ECMO: ECMO Market Revenue and Forecast to 2028 (US$ Million)

7.4         Venovenous ECMO

7.4.1        Overview

7.4.2        Venovenous ECMO: ECMO Market Revenue and Forecast to 2028 (US$ Million)

7.5         Arteriovenous ECMO

7.5.1        Overview

7.5.2        Arteriovenous ECMO: ECMO Market Revenue and Forecast to 2028 (US$ Million)

8.           Europe ECMO Market Analysis – By Application

8.1         Overview

8.2         Europe ECMO Market, By Application 2021 & 2028 (%)

8.4         Respiratory

8.4.1        Overview

8.4.2        Respiratory Market Revenue and Forecast to 2028 (US$ Mn)

8.5         Cardiology

8.5.1        Overview

8.5.2        Cardiology Market Revenue and Forecast to 2028 (US$ Mn)

9.           Europe ECMO Market Analysis – By Age Group

9.1         Overview

9.2         Europe ECMO Market, By Age Group 2021 & 2028 (%)

9.3         Adults

9.3.1        Overview

9.3.2        Adults Market Revenue and Forecast to 2028 (US$ Mn)

9.4         Pediatrics

9.4.1        Overview

9.4.2        Pediatrics Market Revenue and Forecast to 2028 (US$ Mn)

9.5         Neonates

9.5.1        Overview

9.5.2        Neonates Market Revenue and Forecast to 2028 (US$ Mn)

10.        Europe ECMO Market – Country Analysis

10.1      Overview

10.1.2     Europe: ECMO Market, by Country, 2021 & 2028 (%)

10.1.2.1       Germany: ECMO Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.1.1       Overview

10.1.2.1.2       Germany: ECMO Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.1.3       Germany: ECMO Market, By Modality, 2019–2028 (US$ Million)

10.1.2.1.4       Germany: ECMO Market, by Application, 2019–2028 (US$ Million)

10.1.2.1.5       Germany: ECMO Market, by Age Group, 2019–2028 (US$ Million)

10.1.2.2       UK: ECMO Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.2.1       Overview

10.1.2.2.2       UK: ECMO Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.2.3       UK: ECMO Market, By Modality, 2019–2028 (US$ Million)

10.1.2.2.4       UK: ECMO Market, by Application, 2019–2028 (US$ Million)

10.1.2.2.5       UK: ECMO Market, by Age Group, 2019–2028 (US$ Million)

10.1.2.3       France: ECMO Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.3.1       Overview

10.1.2.3.2       France: ECMO Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.3.3       France: ECMO Market, By Modality, 2019–2028 (US$ Million)

10.1.2.3.4       France: ECMO Market, by Application, 2019–2028 (US$ Million)

10.1.2.3.5       France: ECMO Market, by Age Group, 2019–2028 (US$ Million)

10.1.2.4       Italy: ECMO Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.4.1       Overview

10.1.2.4.2       Italy: ECMO Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.4.3       Italy: ECMO Market, By Modality, 2019–2028 (US$ Million)

10.1.2.4.4       Italy: ECMO Market, by Application, 2019–2028 (US$ Million)

10.1.2.4.5       Italy: ECMO Market, by Age Group, 2019-2028 (US$ Million)

10.1.2.5       Spain: ECMO Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.5.1       Overview

10.1.2.5.2       Spain: ECMO Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.5.3       Spain: ECMO Market, By Modality, 2019–2028 (US$ Million)

10.1.2.5.4       Spain: ECMO Market, by Application, 2019–2028 (US$ Million)

10.1.2.5.5       Spain: ECMO Market, by Age Group, 2019–2028 (US$ Million)

10.1.2.6       Rest of Europe: ECMO Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.6.1       Overview

10.1.2.6.2       Rest of Europe: ECMO Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.6.3       Rest of Europe: ECMO Market, By Modality, 2019–2028 (US$ Million)

10.1.2.6.4       Rest of Europe: ECMO Market, by Application, 2019–2028 (US$ Million)

10.1.2.6.5       Rest of Europe: ECMO Market, by Age Group, 2019–2028 (US$ Million)

11.        Industry Landscape

11.1      Overview

11.2      Inorganic Growth Strategies

11.2.1     Overview

11.3      Organic Growth Strategies

11.3.1     Overview

12.        Company Profiles

12.1      Terumo Group

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2      Medtronic Plc

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3      MicroPort Scientific Corporation

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      LivaNova Plc

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5      Nipro Medical Corporation

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6      Eurosets S.R.L.

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7      Getinge AB

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Products and Services

12.7.4     Financial Overview

12.7.5     SWOT Analysis

12.7.6     Key Developments

12.8      Braile Biomedica

12.8.1     Key Facts

12.8.2     Business Description

12.8.3     Products and Services

12.8.4     Financial Overview

12.8.5     SWOT Analysis

12.8.6     Key Developments

12.9      Fresenius Medical Care AG & Co KGaA

12.9.1     Key Facts

12.9.2     Business Description

12.9.3     Products and Services

12.9.4     Financial Overview

12.9.5     SWOT Analysis

12.9.6     Key Developments

12.10   ABIOMED Inc

12.10.1  Key Facts

12.10.2  Business Description

12.10.3  Products and Services

12.10.4  Financial Overview

12.10.5  SWOT Analysis

12.10.6  Key Developments

13.        Appendix

13.1      About The Insight Partners

13.2      Glossary of Terms

 

 

LIST OF TABLES

Table 1.             Europe ECMO Market – Revenue and Forecast to 2028 (US$ Million)

Table 2.             Germany: ECMO Market, By Modality – Revenue and Forecast to 2028 (US$ Million)

Table 3.             Germany: ECMO Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 4.             Germany: ECMO Market, by Age Group – Revenue and Forecast to 2028 (US$ Million)

Table 5.             UK: ECMO Market, By Modality – Revenue and Forecast to 2028 (US$ Million)

Table 6.             UK: ECMO Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 7.             UK: ECMO Market, by Age Group – Revenue and Forecast to 2028 (US$ Million)

Table 8.             France: ECMO Market, By Modality – Revenue and Forecast to 2028 (US$ Million)

Table 9.             France: ECMO Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 10.          France: ECMO Market, by Age Group – Revenue and Forecast to 2028 (US$ Million)

Table 11.          Italy: ECMO Market, By Modality – Revenue and Forecast to 2028 (US$ Million)

Table 12.          Italy: ECMO Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 13.          Italy: ECMO Market, by Age Group – Revenue and Forecast to 2028 (US$ Million)

Table 14.          Spain: ECMO Market, By Modality – Revenue and Forecast to 2028 (US$ Million)

Table 15.          Spain: ECMO Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 16.          Spain: ECMO Market, by Age Group – Revenue and Forecast to 2028 (US$ Million)

Table 17.          Rest of Europe: ECMO Market, By Modality – Revenue and Forecast to 2028 (US$ Million)

Table 18.          Rest of Europe: ECMO Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 19.          Rest of Europe: ECMO Market, by Age Group– Revenue and Forecast to 2028 (US$ Million)

Table 20.          Recent Inorganic Growth Strategies

Table 21.          Recent Organic Growth Strategies

Table 22.          Glossary of Terms

 

 

LIST OF FIGURES

Figure 1.           Europe ECMO Market Segmentation

Figure 2.           Europe ECMO Market, By Country

Figure 3.           Europe ECMO Market Overview

Figure 4.           Europe ECMO Market, By Modality

Figure 5.           Europe ECMO Market, By Country

Figure 7.           Europe: PEST Analysis

Figure 8.           Experts Opinion

Figure 9.           Impact Analysis: Europe ECMO Market

Figure 10.        Europe ECMO Market – Revenue Forecast and Analysis

Figure 11.        Europe ECMO Market Share by Modality 2021 & 2028 (%)

Figure 12.        Venoarterial ECMO: Europe ECMO Market Revenue and Forecast To 2028 (US$ Million)

Figure 13.        Venovenous ECMO: Europe ECMO Market Revenue and Forecast To 2028 (US$ Million)

Figure 14.        Arteriovenous ECMO: Europe ECMO Market Revenue and Forecast To 2028 (US$ Million)

Figure 15.        Europe ECMO Market, by Application 2021 & 2028 (%)

Figure 16.        Respiratory : Europe ECMO Market Revenue and Forecasts To 2028 (US$ MN)

Figure 17.        Cardiology : Europe ECMO Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 18.        Europe ECMO Market, by Age Group 2021 & 2028 (%)

Figure 19.        Adults : Europe ECMO Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 20.        Pediatrics : Europe ECMO Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 21.        Neonates : Europe ECMO Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 22.        Europe: ECMO Market, by Key Country – Revenue (2021) (US$ Million)

Figure 23.        Europe: ECMO Market, by Country, 2021 & 2028 (%)

Figure 24.        Germany: ECMO Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25.        UK: ECMO Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26.        France: ECMO Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27.        Italy: ECMO Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28.        Spain: ECMO Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29.          Rest of Europe: ECMO Market – Revenue and Forecast to 2028 (US$ Million)

  1. ABIOMED Inc
  2. Braile Biomedica
  3. Eurosets S.R.L.
  4. Fresenius Medical Care AG & Co KGaA
  5. Getinge AB
  6. LivaNova Plc 
  7. Medtronic Plc
  8. MicroPort Scientific Corporation
  9. Nipro Medical Corporation
  10. Terumo Group  
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3000
Site License
$4000
Enterprise License
$5000